Skip to Content

Vaccinating Lactating Mothers May Protect Infants From COVID-19

WEDNESDAY, April 21, 2021 -- Antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are detectable in the breast milk of lactating women up to 80 days following COVID-19 vaccination, according to a research letter published online March 30 in the American Journal of Obstetrics & Gynecology.

Jeannie C. Kelly, M.D., from Washington University in St. Louis, and colleagues characterized breast milk levels of anti-SARS-CoV-2 antibodies in five lactating individuals undergoing vaccination with the Pfizer-BioNTech/BNT162b2 vaccine. Participants provided frozen breast milk samples (29) prior to vaccination, within the first 24 hours of vaccination, and weekly following vaccination. SARS-CoV-2 RNA levels in breast milk were assessed using quantitative real-time polymerase chain reaction and anti-spike immunoglobulin (Ig)G and IgA by an enzyme-linked immunosorbent assay.

The researchers found that all prevaccine milk samples tested negative for SARS-CoV-2 RNA. At all time points thereafter, anti-spike IgG and IgA levels were significantly elevated versus prevaccine baseline. At 20 days after the first dose, anti-spike protein IgG remained sustained at a significant elevation compared with baseline. From baseline to the final sample, levels of anti-spike protein IgA were significantly elevated, but individual-level data suggested a possible gradual decline in anti-spike IgA in human milk over time following the second dose.

"We're now seeing a cascade of new data that indicate maternal vaccines are also going to help protect babies -- both through transfer of antibodies through the placenta during pregnancy and through the breast milk during lactation," Kelly said in a statement. "This is information we didn't have a few months ago and it's really helping us better counsel our patients who are considering getting the vaccine."

One author disclosed financial ties to pharmaceutical and medical companies.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Read this next

Efficacy of BNT162b2 mRNA COVID-19 Vaccine Lower in Patients With CLL

THURSDAY, May 6, 2021 -- The BNT162b2 mRNA COVID-19 vaccine has lower efficacy among patients with chronic lymphocytic leukemia (CLL) and induces lower neutralizing antibody...

Cannabis Use Disorder in Pregnancy Tied to Worse Infant Outcomes

THURSDAY, May 6, 2021 -- Prenatal cannabis use disorder (CUD) is associated with higher odds of major adverse neonatal outcomes, according to a study published online April 22 in...

Canada Approves Pfizer COVID-19 Vaccine for Children Ages 12 to 15

WEDNESDAY, May 5, 2021 -- The Pfizer COVID-19 vaccine has been approved by Canadian health officials for use in children ages 12 to 15 years. It was already authorized for anyone...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.